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Abstract
Current three-dimensional (3D) genome modeling platforms are limited by their inability to account for radial
placement of loci in the nucleus. We present Chrom3D, a user-friendly whole-genome 3D computational modeling
framework that simulates positions of topologically-associated domains (TADs) relative to each other and to the
nuclear periphery. Chrom3D integrates chromosome conformation capture (Hi-C) and lamin-associated domain
(LAD) datasets to generate structure ensembles that recapitulate radial distributions of TADs detected in single cells.
Chrom3D reveals unexpected spatial features of LAD regulation in cells from patients with a laminopathy-causing
lamin mutation. Chrom3D is freely available on github.
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Background
Advances in molecular and computational techniques have
enhanced our understanding of the three-dimensional (3D)
organization of eukaryotic genomes [1]. Current interpret-
ation of chromosome-chromosome contacts determined
from genome-wide chromosome conformation capture
(Hi-C) data pictures a hierarchically organized genome
with fundamental ~1 Mb units termed topologically
associated domains (TADs) [2–4]. In mammals, the gen-
omic linear position of TADs and TAD boundaries are
overall conserved between cell types [2, 3]. However, TADs
can differ in their internal chromatin folding patterns,
chromatin states, and transcriptional activity [3], and con-
tacts between TADs can be altered during cell differenti-
ation [5]. While these observations suggest an orchestrated
genome topology [6, 7], processes modulating transcrip-
tional activity of TADs remain largely unknown.
One way for the cell to regulate chromatin activity in
TADs would be to place them in distinct nuclear com-
partments, such as the nuclear interior which is condu-
cive of transcriptional activity or the nuclear periphery
(NP) which provides a more repressive environment. At
the NP, chromatin interacts with the nuclear lamina, a
meshwork of A- and B-type nuclear lamins [8], through
lamin-associated domains (LADs) [9]. While lamin B1
(abbreviated as LMNB1 here) is restricted to the NP,
lamins A and C, splice variants of the LMNA gene
(abbreviated as LMNA), also exist in the nuclear inter-
ior [10] where they seem to play a role in gene regula-
tion and differentiation [11] presumably by interacting
with chromatin [6, 7]. Thus, a dynamic association of
TADs with the NP would constitute a mode of regulation
of transcriptional activity within TADs [3]. However, TAD
positioning in the 3D nucleus space has not been exam-
ined because there are currently no means of assessing
spatial mammalian genome conformation using chroma-
tin anchor-point information. This limits our understand-
ing of principles of genome dynamics.
Chromatin connections with intranuclear structures
such as the nuclear lamina [9] contribute to spatial gen-
ome organization and regulation of gene expression. In
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yeast, attachment of centromeres to the spindle pole
body and tethering of telomeres to the NP [12–14] pro-
vide constraints on chromosome movement which have
proven useful to generate 3D genome structures [15, 16].
These observations suggest that integrating positional
constraints from various genomic datasets, such as
LAD information from chromatin immunoprecipitation
sequencing (ChIP-seq) of nuclear lamins, in addition to
Hi-C, would provide more realistic structures of the
mammalian genome.
A strategy to study genome conformation is to compu-
tationally model 3D structures of chromatin and analyze
the properties of these structures. 3D genome modeling
approaches have been applied at various scales and reso-
lutions [16–33]. One approach to modeling genomes
from Hi-C data is to reconstruct a consensus 3D struc-
ture, using multidimensional scaling [17, 20, 21, 34] or
Bayesian inference methods such as Bayesian 3D con-
structor for Hi-C data (BACH) and derivatives thereof
[35]. Other methods recapitulate structural variations in
genome conformation across cells in a population by
simulating ensembles of structures [18, 19, 24, 28, 31,
35] or by data deconvolution [22, 24, 25, 31, 36]. A
commonly used framework that models ensembles of
structures is the Integrative Modeling Platform (IMP)
[24, 31, 36, 37] (https://3dgenomes.github.io/TADbit).
However, IMP has not been designed for genome mod-
eling and requires advanced programming skills. An-
other constrained optimization approach (BACH-MIX)
designed for local genome modeling, relies on Bayesian
inference of 3D chromosome arrangements to assess
variations in genome structures in a cell population
[35]. BACH-MIX, however, is not designed to incorpor-
ate positional constraints for loci in the nucleus. There
is therefore no user-friendly framework that models the
3D genome over a wide range of scales and that incor-
porates chromosome positional constraints.
We introduce Chrom3D, a genome 3D modeling plat-
form designed to integrate positional constraints based on
association of loci with intranuclear anchors. The combin-
ation of Hi-C and LAD information enables genome-wide
radial positioning of TADs in ensembles of 3D structures.
We also show that Chrom3D provides new opportunities
to investigate mechanisms of spatial gene regulation in dis-
eases susceptible to affect spatial chromatin organization.
Results
A 3D genome modeling framework integrating
chromosomal interactions and radial position information
Chrom3D simultaneously incorporates chromosomal
interaction constraints and constraints from chromosome


























































Fig. 1 Chrom3D integrates Hi-C and nuclear lamin ChIP-seq data to provide an ensemble of 3D genome structures with radial positioning information
of loci. a Chrom3D principles. Hi-C and lamin ChIP-seq data are combined to define beads (TADs) subjected to interaction constraints between them,
based on Hi-C data, or to interaction constraints with the NP, based on LMNA ChIP-seq data (LADs). Hi-C and LAD maps shown are dummies for
explanation purposes. Additional file 1: Figure S2 shows an actual representation of the relationship between TADs and LADs. During a simulation,
TADs are rearranged with a modeled nucleus by a chromosome move (orange arrow) selected among a set of five possibilities (Additional file 1: Table
S1) in order to juxtapose two interacting TADs (red beads), and position a LMNA-associated TAD at the NP (blue bead). Radius of the modeled nuclei is
5 μm. b Loss-score values and representative structures during a simulation; each chromosome is colored differently. c Example of a Chrom3D whole-
genome 3D structure; chromosomes are distinctively colored. d Tomographic views of the structure in (c), showing LMNA-associated TADs
(blue beads), all interacting TAD pairs (red beads), and interacting TAD pairs in which at least one TAD is associated with LMNA (purple “merged”
beads). Gray beads visualize all other TADs. e Percentage of TADs at the NP as a function of Hi-C and LMNA constraints across 400 structures;
**P < 2.2 × 10–16; *P = 8.53 × 10–5 (Mann–Whitney U tests)
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Additional file 1: Figure S1). Each chromosome is mod-
eled as a beads-on-a-string chain where each bead repre-
sents a genomic contact domain (TAD). To develop
Chrom3D, we integrated statistically significant pair-wise
interactions between TADs (interacting TAD pairs) identi-
fied from high-resolution Hi-C data in HeLa cells [38] and
association of TADs with the NP determined by ChIP-seq
of LMNA also in HeLa cells [7] (Additional file 1: Figure
S1). In effect, if a DNA sequence identified as a LAD can
be assigned to a TAD (see “Methods”), Chrom3D will con-
strain this TAD to the NP; we refer to such TADs as
LMNA-associated TADs (Additional file 1: Figure S1).
Chrom3D therefore emphasizes constraints that are sig-
nificantly enriched in the population-based Hi-C and
lamin ChIP-seq data; Additional file 1: Figure S2 depicts
all positional constraints for each chromosome. Instead of
optimizing particular distances between a large number of
bead pairs, our approach enables an emphasis on the sub-
set of bead pairs that significantly interact in the data.
Chrom3D is based on Monte Carlo (MC) optimization
with the goal of minimizing a loss-score function. The
optimization process starts from random self-avoiding
chromosome structures. Using the constraints described
above imposed by TAD-TAD and TAD-LMNA interac-
tions, iteration invokes one of five predefined local bead
moves, affecting one or multiple beads while preserving
bead chain connectivity (Fig. 1a; Additional file 1: Figure
S3). This is in contrast to previous MC-based genome
modeling where each bead is moved independently [18,
24, 31]. We model the genome at TAD (and sub-TAD)
resolution from 13,878 beads, each spanning ~230 kb. In
the simulations, TADs constrained by LADs are pushed
toward the NP while Hi-C-constrained interacting TAD
pairs are attracted to each other. The resulting Euclidean
distances are assessed through a loss-score optimized until
convergence is reached (Fig. 1b). The result of one simula-
tion is a 3D modeled structure of the entire human gen-
ome where the concept of chromosome territories is
respected (Fig. 1c; see also below for analysis of modeled
chromosome territories). Of note, the lamin constraint is
neutral with respect to the detection of chromosome
territories in the modeled structures (Additional file 1:
Figure S4a).
Since the optimization method is non-convex, a given
simulation run may result in the representation of a struc-
ture from a local optimum in the loss-score function.
Thus, to obtain a statistical estimate of the variability in
the optimized structures, we generated 400 structures,
each from 2 × 106 iterations. We show that TADs associ-
ated with LMNA are mainly placed towards the NP
whereas interacting TAD pairs without a LMNA-directed
peripheral positional constraint are more evenly distrib-
uted in the nucleus (Fig. 1d, e). Interaction matrices
reconstructed from the modeled structures show strong
correlation with matrices generated from input Hi-C data
for all chromosomes, providing validation to the struc-
tures (Additional file 1: Figure S5). We then defined the
NP as a 1 μm thick outer “shell” partitioning the modeled
nucleus into two compartments of equal volumes (Fig. 2a).
As expected from microscopy observations, computation
of chromatin (bead) density as a function of distance from
the nucleus center shows that chromatin is not uniformly
distributed in the modeled nuclei (Additional file 1: Figure
S4b). Moreover, we find that across the 400 structures,
gene density and expression level are lowest in TADs posi-
tioned at the NP (Fig. 2b, c). This is consistent with the
gene-poor content and overall heterochromatic state of
chromatin in this compartment [9]. Chrom3D therefore
enables the reconstruction of 3D genome structures in-

























































Fig. 2 Characterization of TADs modeled at the NP and in the
nucleus center. a Definition of periphery, center, and intermediate
regions used to ascribe a radial position of TADs in Chrom3D
structures. Volumes of the peripheral 1 μm thick “shell” (light gray)
(NP) and of the nucleus “core” (dark gray) are equal, given a nucleus
of 5 μm radius. A TAD is assigned to the NP if placed in the shell
in > 67% of 400 structures, to an “intermediate” location if placed in
the shell in 33–67% of the structures, and to the center if placed in
the shell in < 33% of the structures. b Gene density and (c) gene
expression level in TADs positioned at the periphery, center, or
intermediate regions across 400 structures. FPKM values in (c) are
from RNA-sequencing data downloaded from NCBI GEO accession
number GSE33480
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Comparison of Chrom3D with IMP
We next compared Chrom3D with IMP, a popular
framework for ensemble 3D genome modeling. To this
end, we customized IMP to include LAD information as
radial positional constraints. Simulation time is slightly
faster with Chrom3D (Additional file 1: Figure S6a). Im-
portantly, IMP tends to draw LMNA-containing TADs
(beads) to the NP by stretching distances between con-
secutive beads, thereby violating chain continuity, espe-
cially for TADs associated with LMNA (Additional file 1:
Figure S6b, c). We attributed this to IMP’s permutation
strategy which involves randomly repositioning single
beads, whereas by design Chrom3D always connects beads
(Additional file 1: Figure S6b, red line). Moreover, using
many beads, IMP generates large and intermingled chro-
mosomes (Additional file 1: Figure S6d, e) that are less el-
lipsoidal and with greater variation in asphericity, beyond
the 1–2 μm radius of chromosome territories estimated
from microscopy studies [39] (Additional file 1: Figure S6f,
g). This is likely due to initialization in an unconnected
configuration. Thus, despite IMP’s suitability for 3D gen-
ome modeling of coarse-grained systems, Chrom3D more
favorably models 3D genome structures with bead sizes at
TAD and sub-TAD resolution from the constraints im-
posed in our system.
Chrom3D is able to model local chromatin conformation
We assessed whether Chrom3D was scalable to restriction
fragment-level size by modeling the ENCODE ENm008
region containing the α-globin locus, whose 3D conform-
ation has been inferred from 5C data [18]. Clustering of
1000 Chrom3D-simulated conformations with no lamin
constraint (see “Methods”) reveals greater structural vari-
ability in erythroleukemia K562 cells where the α-globin
gene is expressed, than in lymphoblastoid GM12878 cells
where it is repressed (Additional file 1: Figure S7a).
Chrom3D structures also show compactness of the locus
consistent with the previous structure and fluorescence
in situ hybridization (FISH) data and with expression of
the gene in these cell types [18] (Additional file 1:
Figure S7b–d). We conclude that Chrom3D is also
suited for structural chromatin modeling at the gene
locus level.
TADs associated with LMNA are more centrally placed
than those associated with LMNB1
Association of TADs with the nuclear lamina and inter-
actions between TADs reflect complementary but also
potentially conflicting information on spatial positioning:
two TADs may be predicted to interact, but peripheral
assignment of only one (if associated with LMNA) may
preclude them from being juxtaposed. Accordingly, we
find that 40% of TADs associated with LMNA are placed
in the peripheral 1 μm shell in our structures (Fig. 3a).
This indicates that not all TADs associated with LMNA
can be assigned to the NP in a given structure. We next
modeled the radial placement of TADs in 400 new
structures modeled using either LMNA or LMNB1 [7]
as peripheral constraints. The results show that a LMNA
constraint is less consistent with TAD placement at the
NP than a LMNB1 constraint (Fig. 3a; P = 9.53 × 10–7;
Wilcoxon signed-rank test), in line with a role of
LMNA in chromatin organization also in the nuclear
interior [6, 40].
Previous FISH analysis simultaneously probing 25
LMNB1 LADs in single HT1080 cells show that only
32% of LADs can be simultaneously detected at the NP
(defined there as < 0.7 μm, or 8 pixels, from the nucleus
edge) in a given nucleus [41]. This proportion is remark-
ably similar to that of TADs associated with LMNB1
localized within 0.7 μm of the nucleus edge across our
400 Chrom3D structures (30.5%; Fig. 3a, inset). It is also
higher than that of LMNA-associated TADs modeled at
the periphery (25%; P < 2.2 × 10–16; Mann–Whitney U
test). This again indicates that not all LADs can be
assumed to be found at the NP in individual nuclei in a
cell population. This may be because some regions only
transiently contact nuclear lamins at the NP and are
therefore mainly detected in the nuclear interior.
Assessment of chromatin stability at the nuclear periphery
Our previous results suggest that Chrom3D can recap-
itulate structures of genome conformation at the single-
cell level. To further assess this contention, we examined
the consistency of assignment of TADs at the NP across
structures, with the rationale that this would reflect sta-
bly positioned TADs in this compartment across cells in
a population. Chromosomal heatmaps of radial place-
ment of TADs in structures modeled using LMNA or
LMNB1 constraints reveal TADs with constitutive place-
ment at the NP (<1 μm from the nucleus edge) or in the
nucleus center and TADs with intermediate placement
(Fig. 3b). As expected, the most stable peripheral TADs
are located on the largest and most gene-poor chromo-
somes, while smaller gene-rich chromosomes harbor
TADs more centrally placed (Fig. 3b). We find, however,
no correlation between TAD size and peripheral stability
of TADs across structures, indicating that the attribution
of TADs from large chromosomes to the NP is not
merely caused by TAD size (r = 0.16; Additional file 1:
Figure S8). There is also concordance of radial position-
ing of TADs based on LMNB1 or LMNA constraints
(Fig. 3b, c), consistent with the bulk of LMNA being
enriched in the peripheral lamina. Moreover, subtelomeric
regions appear overall more centrally placed than pericen-
tromeric regions that are more stably ascribed to the NP
(Fig. 3b), corroborating previous FISH data [42, 43]. The
patterns and consistency of radial assignment of TADs
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across our ensemble of structures indicate that Chrom3D
can capture principles of chromatin organization in single
cells.
Features of LADs estimated from the structures concur
with lamin-genome contact patterns observed in single
cells
We next compared our three radial placement categories
(center, intermediate, periphery; see Fig. 2a) with single-
cell NP-genome contact frequencies. These were defined
by association of chromatin with the nuclear lamina
observed in a previous single-cell LMNB1 DamID study
in the near-haploid KBM7 cell line, the only cell type for
which to our knowledge LADs have been mapped at the
single-cell level [44]. Despite the difference in ploidy be-
tween HeLa and KBM7 cells, our structure ensembles
reveal features of genome organization inferred from
the single-cell observations. Indeed, TAD sequences
assigned to the periphery in our structures show the
highest peripheral contact frequency calculated from
the single-cell LMNB1 DamID data and, conversely,
the central category shows the lowest peripheral con-
tact frequency in the single-cell dataset (Fig. 3d). Re-
peating this comparison excluding the lamin constraint
in our modeling shows strongly reduced assignment of
the regions to the periphery (Fig. 3d; P = 4.34 × 10–5 to
P < 2.2 × 10–6; Mann–Whitney U tests). Moreover, fo-
cusing on LADs, our structures predict that larger
LADs are more stably assigned at the periphery than
smaller LADs (Fig. 3e; P = 1.23 × 10–6; Mann–Whitney
U tests), again in agreement with the single-cell obser-
vations [44]. Our predictions of lower gene density and
a b
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Fig. 3 Chrom3D genome structures recapitulate features of genome organization estimated from single-cell analyses. a Percentage of LMNA-
associated or LMNB1-associated TADs at a given distance from the NP across 400 structures; data are shown for TAD placement using LMNA
or LMNB1 as radial constraint. P value for difference between the two curves is 9.53 × 10–7 (Wilcoxon rank sum test). Inset: percentages of LMNA-
associated or LMNB1-associated TADs positioned at 0.7 μm from the nucleus edge shown for comparison with FISH data for LADs (see [41]);
P < 2.2 × 10–16 (Mann–Whitney U test). b Heatmaps of radial stability of LMNA-associated or LMNB1-associated TADs in all chromosomes across
400 structures. “Blue” TADs are more stably placed in the nucleus center than “red” TADs, which are more stably placed at the NP. c Correlation
analysis of lamin-associated TAD placement at the NP across 400 structures modeled with LMNA or LMNB1 constraints. d Comparison of TAD
placement TADs modeled by Chrom3D with LMNB1 association frequency from the LMNB1 DamID in single cells [44]. Left, proportions of center,
intermediate, and peripheral TADs in our structures associated with LMNB1 in the single-cell dataset; *P < 2.2 × 10–16 (Mann–Whitney U tests).
Right, same as above, for TADs whose placement was modeled without lamin constraints; *P < 2.2 × 10–16; nsP = 0.755 (Mann–Whitney U tests).
Comparisons between LMNB1 and no lamin constraint data: **P = 4.34 × 10–5, ***P = 6.20 × 10–5, ****P < 2.2 × 10–16, Mann–Whitney U tests. e Size
distribution of LMNB1 LADs [44] in the structures; *P = 1.17 × 10–3; **P = 1.23 × 10–6; §P = 6.32 × 10–3 (Mann–Whitney U tests)
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expression level in peripheral TADs (see Fig. 2b, c) are
also supported by the single-cell data. We conclude that
our ensemble of structures reflects the radial localization
of LADs observed in single cells.
FISH validates LADs modeled in the nuclear periphery
and nuclear interior
To validate the position of LADs predicted from the
modeled structures, we carried out a FISH analysis. We
analyzed 1105 FISH signals obtained from FISH probes
designed to LMNA LADs placed at the NP, towards the
nucleus center or in intermediate radial positions in the
structures (Additional file 1: Table S1 and Figure S9a).
The observed radial distribution of LADs from FISH ana-
lysis strongly concurs with predictions from the modeled
structures (Fig. 4a–d; r = 0.91; Additional file 1: Figure
S9b–d). To further appreciate the spatial coverage of indi-
vidual chromosomes, four FISH probes were designed to
chromosome 4 (Additional file 1: Figure S9e, f ). Observed
distributions of 453 FISH signals again agree with their
predicted distribution (r = 0.97; Additional file 1: Figure
S9g–i). These results validate the structures and indicate
that LADs can be found in peripheral and central nuclear
compartments. LAD distribution across structures also re-
capitulates their localization visualized in single cells.
Chrom3D reveals laminopathy-specific LADs and differential
gene regulation in the nucleus interior
Mutations in LMNA cause laminopathies which affect
specific tissues [45] through still largely unknown mecha-
nisms. The roles of LMNA on chromatin organization
and mobility [46, 47] suggest that laminopathies may
involve altered interactions of LMNA with chromatin in
distinct nuclear compartments. This, however, has not
been examined due to a lack of suitable tools. To gain 3D
insight on chromatin changes that might be associated
with LMNA mutations, we used Chrom3D to model the
radial distribution of LADs associated with wt or mutated
LMNA.
First, we expressed in HeLa cells: (i) a flag-tagged
version of a LMNA mutation, LMNA(R388P), causing
congenital muscle dystrophy and lipodystrophy (Barateau
et al., manuscript submitted); (ii) wt LMNA; and (iii) a


















































































































































Fig. 4 Validation of Chrom3D structures by FISH. a Expected radial distribution of ten FISH probes designed to the nucleus center (3 c probes),
intermediate (4 i probes), and peripheral (3 p probes) areas, across 400 structures; *P < 2.2 × 10–16 (Mann–Whitney U tests). b Observed radial
distribution of 1105 FISH signals for the ten probes analyzed in (a); *P < 10–4; ns, non-significant (Mann–Whitney U tests). Quantitative data for
each individual probe are shown in Additional file 1: Figure S9b, c. c Correlation between observed and expected relative distance of FISH signals
to the NP. d Examples of FISH images for each radial category (planar and orthogonal views); periphery, probe p1; center, probe c3; intermediate,
probe i1. Bar, 5 μm
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that localizes only at the NP by retention of its prela-
min A-associated farnesyl moiety (Additional file 1: Fig-
ure S10a, b). We next mapped LADs associated with
these LMNA proteins by ChIP-seq using anti-Flag anti-
bodies. While LMNA wt and LMNA (L647R) LADs reveal
strong overlap, there is little overlap between R388P LADs
and wt or L647R LADs (Fig. 5a, b; Additional file 1: Figure
S10b, c). Superimposition of wt and mutant LADs on 400
Chrom3D HeLa structures strikingly reveals that R388P
LADs map more frequently to the nuclear center than
wt or L647R LADs (Fig. 5c, d). Validating these predic-
tions, immunofluorescence analysis shows that the
LMNA(R388P) mutant is indeed distributed throughout
the nucleoplasm, accounting for the intranuclear position-
ing of the majority of R388P LADs (Fig. 5e; Additional file
1: Figure S10d). Furthermore, R388P LADs are gene-rich
(Fig. 5f) and narrower (Fig. 5g) than wt or L647R LADs
(P < 2.2 × 10–16; Mann–Whitney U tests). These observa-
tions are again consistent with the radial placement of
these LADs predicted by Chrom3D (Fig. 5c). These find-
ings importantly indicate that Chrom3D can reveal radial
positioning of loci without prior knowledge of their
localization.
Next, we determined whether Chrom3D could provide
new insights into laminopathies by modeling the 3D
genome in cells from patients harboring a LMNA muta-
tion. We mapped by ChIP-seq using anti-lamin A/C anti-
bodies, LMNA LADs in fibroblasts from four patients
with familial partial lipodystrophy of Dunnigan type
(FPLD2; OMIM#151160; patients “p1–p4”) bearing the
same heterozygous LMNA p.R482W mutation [49] and
in fibroblasts from three healthy control individuals.
We examined the R482W LMNA mutant because the



























































































































Fig. 5 Differential radial positioning of TADs associated with peripheral and nucleoplasmic LMNA mutants. a ChIP-seq profiles (log(ChIP/input))
and corresponding LADs for flag-tagged LMNA wt, Flag-LMNA(L647R), Flag-LMNA(R388P), and endogenous LMNA in HeLa cells. b Venn diagram
analysis of LAD overlaps (in Mb). c Radial distribution of TADs associated with Flag-LMNA wt, Flag-LMNA(L647R), and Flag-LMNA(R388P) across 400
structures modeled for each LMNA construct. d TADs associated with LMNA wt, LMNA R388P, or LMNA L647R (colored beads) superimposed onto
all TADs (gray beads) in a modeled HeLa nucleus. e Immuno-localization of Flag-LMNA proteins and quantification of localization patterns (graph;
> 300 nuclei per condition). f Gene density within indicated LADs and in the whole human genome. g LAD size distribution; *P < 2.2 × 10–16
(Mann–Whitney U tests)
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nucleosome binding to LMNA in vitro [50, 51], and
thus might affect LMNA association with chromatin in
patient cells. Genome browser views of LMNA enrich-
ment and detected LADs, and LAD overlap analyses,
show that LMNA LADs in control and FPLD2 cells are
overall conserved (Fig. 6a) but also show differences in
genome coverage (Fig. 6b, c; Additional file 1: Figure
S11a–c). Differential LMNA-chromatin association was
corroborated by ChIP-quantitative polymerase chain re-
action (qPCR) analysis of 16 genic and ten intergenic
loci in fibroblasts from three patients and two controls
(Additional file 1: Figure S11d, e).
Using Chrom3D, we generated 100 structures for
each of the control and patient fibroblasts by integrat-
ing control and FPLD2 LMNA LAD datasets with TAD
information from published Hi-C data for IMR90
human fibroblasts [38]. We find that strikingly, LADs
specific to FPLD2 patients (LADs “gained” in FPLD2
fibroblasts) are more centrally located than all LADs in
these cells (Fig. 6d, bars 2, 6; P < 2.2 × 10–16, Mann–Whit-
ney U test); these domains are also centrally placed in con-
trol cells (Fig. 6d). In contrast, LADs unique to control
fibroblasts (“lost” in patient cells) are found at the NP, to
the same extent as all LADs in these cells (Fig. 6d; bars 3,
5; P = 0.35). Figure 6e shows examples of peripherally
placed “lost” LADs in a modeled control nucleus and cen-
trally placed “gained” LADs in an FPLD2 nucleus. We
nevertheless note that a gain or loss of LADs is associated
with partial recruitment of these regions towards, or away
from, the NP, respectively (Fig. 6d, bars 1, 2; P < 2.2 × 10–16
and bars 3, 4; P < 2.2 × 10–16). These findings imply that
LADs gained in patient cells are mainly restricted to
the nuclear interior and are unexpectedly not fully
repositioned to the NP. In addition, a gain or loss of
LADs correlates with overall downregulation or upreg-
ulation, respectively, of gene expression within them
125.7141.2 277.4
All controls All FPLD2
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Fig. 6 Chrom3D modeling of positioning of TADs containing laminopathy-associated LMNA LADs in FPLD2 patient cells reveals disease-specific
LADs in the nuclear interior. a LMNA ChIP-seq profiles (shown as log(ChIP/input) ratios; scales: –3 to 3 centered on 0) and LADs in control and
FPLD2 fibroblasts. b Example of differential LMNA enrichment patterns in control and FPLD2 fibroblasts. c Overlap of control and FPLD2 LADs
(in Mb). Jaccard index of overlap is 0.51. Control-specific LADs (141.2 Mb) were determined by LAD regions found in at least one control cell
type and not in any of the FPLD2 fibroblasts; FPLD2-specific LADs (125.7 Mb) were determined by LAD regions found in at least one FPLD2
fibroblast type and not in any of the controls. LADs were identified as described in “Methods.” d Radial distribution of all TADs containing LADs
across 100 Chrom3D structures modeled from control and FPLD2 nuclei (bars 5.6) and of TADs containing FPLD2-specific LADs (bars 1, 2) and
control-specific LADs (bars 3,4), both in control nuclei (blue bars) and FPLD2 nuclei (green bars); *P < 2.2 × 10–16 (Mann–Whitney U tests). e Radial
placement of TADs containing control-specific LADs (blue beads) in a modeled control nucleus and of FPLD-specific LADs (green beads) in a modeled
FPLD2 nucleus. f Fold-change expression level of genes within FPLD2-specific (“gained”) LADs in FPLD2 fibroblasts and within control-specific (“lost”)
LADs in control fibroblasts; data expressed as log2(FPKM patients/FPKM controls); numbers are number of outliers; *P = 3.8 × 10–9 (Mann–Whitney U
test). g Expression levels of all genes and of genes in LMNA LADs in FPLD2 and control fibroblasts; *P < 2.2 × 10–16 (Mann–Whitney U test)
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(Fig. 6f; P < 2.2 × 10–16, Mann–Whitney U test), provid-
ing functional significance to the differential LMNA as-
sociations identified in FPLD2 patient cells. This is in a
context of similar range of expression levels of all genes
and of genes within LADs, both in patient and control
cells (Fig. 6g).
Providing additional biological meaning to the modeled
structures, Gene Ontology enrichment analysis highlights
distinct functions of genes found in control-specific LADs
(signaling and metabolic processes) and FPLD2-specific
LADs (developmental processes; Additional file 1: Table
S2). Interestingly, relevant for the metabolic phenotype of
FPLD2 patients [49], the gained and lost LADs in patient
fibroblasts contain genes implicated in white and brown
adipocyte differentiation and metabolism (e.g. PRDM16, a
master regulator of adipose tissue browning, RARRES2,
LGR4, BCATENIN, PLCB1, PTGS2, FABP4, RSPO3, and
EIF2AK3). Predictions emerging from this modeling
therefore suggest that adipogenic and metabolic defects in
FPLD2 patients with the LMNA p.R482W substitution
might be associated with a deregulation of LADs in the
nuclear interior and not exclusively at the nuclear enve-
lope. This could speculatively involve differential bind-
ing of lamin A/C to promoters [52]. Our 3D genome
modeling framework paves the way to more targeted
investigations of disease mechanisms affecting genome
architecture.
Discussion
We present Chrom3D, a software for 3D genome model-
ing based on the inclusion of positional input constraints
from chromosomal interactions (Hi-C data) and nuclear
lamin-chromatin associations (lamin ChIP-seq data).
Several key features of our modeled structures are shown:
inclusion of radial positional constraints, scalability from a
single locus to the whole human genome, and predictive
value of radial placement of TADs. Chrom3D is versatile
in that other positional constraints can be integrated.
Finally, we show an application of Chrom3D to the study
of disease mechanisms using FPLD2 patient-specific pos-
itional constraints imposed by a LMNA mutant displaying
alterations in its association with the genome. Incorpor-
ation of radial positional constraints provides new insight
into the placement of genomic regions in the 3D mamma-
lian nucleus space with respect to the NP, which has not
been possible from current genome modeling plat-
forms. Our ensembles of structures reveal information
on the cell-to-cell variation in genome structures likely
to exist in a cell population. They recapitulate the per-
ipheral positions of TADs in single cells and notably
ascribe a subset of LMNA-associated TADs, and
thereby LADs, in the nuclear interior without prior
knowledge of such localization. Inference of an intra-
nuclear localization of LMNA LADs concurs with the
nuclear distribution of A-type lamins [40] and with
their association with euchromatin, including active
genes [6, 7, 53], which is enriched in the nuclear inter-
ior. Our structures therefore have predictive capacity.
We exploit this property to infer the internal positioning
of LADs associated with a pathological LMNA(R388P)
mutation, after superimposition of these LADs onto struc-
tures. This concurs with the only information currently
available on this lamin mutant, namely LAD data deter-
mined by ChIP-seq of an epitope-tagged version of this
mutant, and its localization throughout the nucleoplasm
visualized by immunostaining. Our findings illustrate
the benefit of optimization-based 3D modeling to un-
veil the interplay between factors determining 3D gen-
ome structure.
The predictive capacity of our structures has important
implications in understanding the relationship between
genome structure and disease [54, 55]. Chrom3D structures
enable a gain of spatial insight into disease-causing mecha-
nisms, e.g. laminopathies as illustrated here. The structures
reveal how alterations in LMNA-chromatin associations
specific to FPLD2 patients with the LMNA(R482W) substi-
tution predictively occur centrally in the nucleus and not
necessarily at the NP as one might have expected. This
opens the door to better targeted molecular investigations
of the disease. Our modeling approach should not only be
applicable to other laminopathies, but also potentially to
diseases linked to dysfunction or mis-regulation in other
nuclear components.
Challenges remain, however, before 3D genome mod-
eling can be routinely applied in disease contexts. First,
the genome must be modeled at appropriate spatial
resolution to infer significant associations between gen-
ome structure and disease mechanisms; this may be re-
quired, for instance, to place selected genes and other
genomic elements into correct regulatory neighbor-
hoods. We have modeled the genome at TAD and sub-
TAD resolution, providing high resolution structures of
the diploid human genome. We do not imply that TADs
exist as structural units at the single-cell level, but TADs
reflect statistically enriched topological domains that
prove to be relevant units for modeling. Second, the size
and complexity of the human genome necessitate some
level of coarse graining for any 3D modeling exercise.
Thus, a tradeoff between resolution and throughput of
structures is inevitable: we have focused here on an ele-
vated number of beads in our structures and a smaller en-
semble of structures. Nevertheless, we show how critical
insights into cell-to-cell variability of genome structures
can be gained from radial positioning constraints.
Conclusions
Chrom3D is a genome 3D modeling platform integrating
Hi-C data together with positional constraints from the
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association of loci with intranuclear anchors such as nu-
clear lamins. While pairwise domain interactions are im-
portant to enforce contacts between distal genomic
regions, radial positioning provides key information on
the spatial organization of genomic domains. Incorpor-
ation of radial positioning constraints in 3D genome
structures enables the study of spatial gene regulation in
disease, for example so-called nuclear envelopathies,
caused by mutations in nuclear envelope proteins.
Extending positional information to other chromatin
anchor points in the nucleus should expectedly enhance




HeLa cells (American Type Culture Collection; CCL-2)
were cultured in MEM medium containing Glutamax
(Gibco), 1% non-essential amino acids and 10% fetal calf
serum. Cells were transfected using XtremeGENE 9
(Roche) using a 3:1 ratio (μL:μg) of X-tremeGENE 9
DNA Transfection Reagent and DNA. Primary skin
fibroblast cultures were established from healthy volun-
teers aged 20 years and 33 years (CTL-1, CTL-3) and
from four patients with familial partial lipodystrophy of
Dunnigan type (FPLD2) due to a LMNA p.R482W het-
erozygous mutation (female, age 43 years (“FPLD-p1”
patient), female, age 37 years (FPLD-p2), female, age
14 years (FPLD-p3), male, age 43 years (FPLD-p4) [56].
These studies were approved by the Institutional Review
Board of Hôpital Saint Antoine (Paris, France). Normal
skin fibroblasts were also purchased from Lonza (“CTL-
2”). Fibroblasts were cultured in DMEM/F12/10% fetal
calf serum, 10 ng/mL epidermal growth factor, 24 ng/
mL basic fibroblast growth factor, and 1% Penicillin-
Streptomycin. Cultures were at passage 5–7 when used.
Plasmids
pCMV-Flag-preLA-WT and pCMV-Flag-preLA-L647R
vectors were generated by LMNA amplification of
pSVK3-Flag-preLA-WT and pSVK3-preLA-L647R [50],
with the 5′ CCGGATCCTATGGAGACCCCGTCCCA
GCGG-3′ and 5′ GCGAATTCTTACATGATGCTGC
AGTTCTG-3′ primers and insertion of the PCR
product into pCMV-Flag at BamH1 and EcoRI sites.
pCMV-Flag-preLA-R388P was constructed from pCMV-
Flag-preLA-WT using the QuikChange Lightning Site-
Directed Mutagenesis Kit (Agilent Technologies). pCMV-
Flag-preLA-wt was amplified by PCR using 5′-GAGGA
GAGGCTACCACTGTCCCCCAGC-3′ and 5′-GCTGG
GGGACAGTGGTAGCCTCTCCTC-3′ primers, prod-
ucts digested by DpnI and XL10-Gold® ultracompetent
cells were transformed. pEGFP-preLA-R388P was con-
structed by LMNA amplification of pCMV-Flag-preLA-
R388P with the 5′ GCCCTAGGTGAGGCCAAGAAGC
AACTT 3′ and 5′ GCCCATGGACTGGTCCTCATTGG
ACTTGT 3′ primers and insertion of the PCR product
into pEGFP-preLA-wt at EcoNI and PflMI sites.
Immunofluorescence
Cells grown on coverslips were fixed 24 h after transfec-
tion with 3% paraformaldehyde, permeabilized in PBS/
0.5% Triton X-100, and incubated in PBS/0.1% Triton X-
100/2% BSA for 25 min. Cells were incubated for 30 min
each with primary and secondary antibodies in PBS/0.1%
Triton X-100/1% BSA. Antibodies were anti-Flag (1:200;
Sigma), anti-lamin A/C [50] (1:400), and anti-rabbit Alex
Fluor® 594 (1:200; Jackson ImmunoResearch). DNA was
stained with Hoechst 33258. Coverslips were mounted
with Mowiol and examined on a LSM 700 confocal micro-
scope (Zeiss) at the Imaging Facility of the Functional and
Adaptive Biology Unit of University Paris Diderot/CNRS.
Immunoblotting
Proteins were separated by SDS-PAGE and transferred
onto nitrocellulose. Membranes were incubated with anti-
lamin A/C [50] or anti-GAPDH antibodies (1:15,000;
Sigma) and with horseradish peroxidase-conjugated anti-
bodies (1:20,000; Promega). Signals were detected by
enhanced chemiluminescence.
RNA-sequencing
Total RNA was isolated from control and FPLD2 fibro-
blasts using the Ambion TRIzol® Reagent RNA extraction
kit (Life Technologies) [57]. Libraries were sequenced on
an Illumina HiSeq2500. RNA-sequencing (RNA-seq)
reads were processed using Tuxedo [58]. TopHat [59] was
used to align reads to hg19 applying the Bowtie 2 [60] pre-
set “very sensitive.” Gene ontology analysis was done with
topGO in R [61].
ChIP of LMNA and LAD identification
ChIP of Flag-LMNA proteins in HeLa cells was done
using anti-Flag antibodies (20 μg/107 cells) as described
[57]. ChIP of LMNA from fibroblasts was done using
anti-lamin A/C antibodies [57]. Illumina libraries were
sequenced on a HiSeq2500. DNA was also used as tem-
plate for qPCR (Additional file 1: Table S3), with 95 °C
for 3 min and 40 cycles of 95 °C for 30 s, 60 °C for 30 s,
and 72 °C for 30 s. Sequence reads were aligned to hg19
genome using Bowtie2 with default parameters and
option -best enabled. LADs were called using Enriched
Domain Detector [57] using a 1-kb bin size and default
parameters. Browser files were generated from the ratio
of ChIP/input for each 1-kb bin with input normalized
to ratio of [total ChIP reads/total input reads]. Scripts
were written in Perl [62] or R [61].
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TAD and bead definition
Genomic positions of TADs were based on contact do-
mains identified from Hi-C data [38] accessed under
GEO GSE63525. Overlapping TADs were merged into
single domains and regions not covered by a TAD were
assigned a bead of size proportional to the correspond-
ing genomic region. Bead sizes were scaled so that total
bead volume constituted 15% of the volume of a 10-μm
diameter modeled nuclei [63], using a previous scaling
function [24].
Assigning lamin information to TADs
TADs that overlap, fully or partially, with a called peak
from lamin ChIP-seq data (i.e. a LAD) [57] were desig-
nated as LMNA-associated or LMNB1-associated TADs
and were constrained towards the NP. This resulted in
1718 LMNA-associated TADs (see Additional file 1:
Figure S1 and S2, blue segments) and 2770 LMNB1-
associated TADs.
Inference of significant interactions from Hi-C data
Interactions between beads were defined from high-
resolution Hi-C data for HeLa cells [38] accessed under
dbGap number phs000640. To infer statistically significant
interactions, we adapted the ChiaSig method designed for
ChlA-PET [64] to Hi-C. To this end, we estimated the de-
pendency between linear genomic distance and contact
frequencies using 1-Mb bins. Refinement of genomic dis-
tance–contact frequency relationship was not necessary
because most pairwise combinations of bins reflect back-
ground looping information. To estimate background
distribution for inter-chromosomal interactions, we used
the average number of inter-chromosomal interactions
between all pairs of bins between chromosomes. ChiaSig
calculates a P value based on the probability of observing
a given number of contacts conditional on the total
number of contacts for both regions involved, as well
as the total number of contacts, using a non-central
hypergeometric distribution. This adjusts for the pro-
pensity of different regions to be involved in contacts,
including technical bias (GC-content, accessibility).
Intra-chromosomal interactions were selected with
FDR 0.01% [21]. For inter-chromosomal interactions,
we also required that interactions be significant in
HeLa cells and in > 4 of the seven cell lines analyzed
previously (GM12878, HMEC, HUVEC, IMR90, K562,
KBM7, NHEK) [38].
This resulted in 3824 significant interactions (3657
intra-chromosomal and 167 inter-chromosomal) for HeLa
(see Additional file 1: Figure S2, red segments). For
IMR90, we obtained 2349 significant interactions (1558
intra-chromosomal and 791 inter-chromosomal). These
interactions were associated with TADs by mapping the
mid-point of each Hi-C bin to the corresponding TAD.
This resulted in 2586 beads for HeLa cells and 1744 beads
for IMR90 (each × 2 to account for a diploid genome) with
at least one interaction.
Peripheral, central, and intermediate assignment of TADs
in the modeled structures
To examine genomic properties of TADs as a function of
radial position in the modeled nuclei, we divided the
nucleus into a peripheral “shell” 1.03-μm thick and a
central compartment, each making up 50% of the total
nucleus volume. A TAD was assigned to:
 the NP if placed in the shell in > 67% of 400
structures;
 an “intermediate” location if placed in the shell in
33–67% of the 400 structures;
 the nucleus center if placed in the shell in < 33% of
the 400 structures.
Chromatin modeling framework
We developed a software suite for MC optimization and
modeling of chromatin 3D structure using C++. Simula-
tions were done using this software, except for when IMP
was used for comparison. The concept is to enable incorp-
oration of constraints and enable MC optimization by in-
voking local perturbations on chromosome regions. These
chromatin “moves” have the favorable property that they
alter only a small part of chromatin structure in each iter-
ation, while maintaining connectivity of the chromatin
chain. This is in contrast to previous MC-based methods
[28] where each bead is moved independently. During
simulation, moves are selected randomly according to
weights specified by the user. In all simulations carried
out here, these weights were set equal, such that each
move has the same chance of being selected in each iter-
ation. For a given structure, we defined a loss-score (L) as









where the sum runs over all bead positions where a con-
straint has been defined and dij is the target Euclidean
distance of the given pair of beads i and j. Beads to be
associated with the NP are optimized according to the
distance from a “dummy bead” assigned in the nucleus
center (the origo). The dummy bead has a radius of 0
and is in all instances (except for loss-score calculations)
not considered as part of the modeled structure. Each
constraint can be weighted by a factor kij, to allow for
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selected constraints to be prioritized in the MC
optimization. Target distance of all bead pairs con-
strained by a Hi-C interaction between them was set to
the sum of the radii of the two beads, effectively minim-
izing the distance between them without bead overlap.
For beads constrained by LADs, target distance (from
the nucleus center) was set to the difference between the
nucleus radius and the bead radius, allowing lamin-
constrained beads to move to the nuclear “wall.” All non-
lamin beads were pulled towards the center by minimizing
their distance to the nucleus center (“dummy bead”). At
the start of each simulation, we initialize the modeling
based on self-avoiding random walk structures sampled
such that none of the chromosomes clash or overlap. We
perturb the structure using the “moves” and minimize the
loss-score using simulated annealing. A move was ac-
cepted based on resulting Euclidian distances between
interacting TADs or between TADs and the NP, according
to the Metropolis–Hastings algorithm with simulated
annealing. Moves causing a clash between beads were
discarded.
Chrom3D software and documentation can be freely
accessed at: https://github.com/CollasLab/Chrom3D.
The version of the source code used in the manuscript
is available at: https://doi.org/10.5281/zenodo.168212
Comparisons of Chrom3D with IMP
We developed a modeling procedure based on IMP using
the same set of constraints and number of beads as for
Chrom3D. We initialized TAD beads as particles and
added “ExcludedVolumeRestraint” to disable bead–bead
clashes. For each consecutive pair of beads on each
chromosome, we added harmonic springs with a spring
distance equal to the two radii of the beads. Interac-
tions between non-consecutive beads (based on Hi-C)
were modeled using harmonic springs with a distance
corresponding to the sum of the radii of the bead pair,
similarly to Chrom3D. Beads with lamin constraints
were pushed to the NP using the “HarmonicLower-
Bound” and a “dummy bead” placed in the nucleus cen-
ter. Spring distance from the lamin-bead and the
dummy bead was set to nucleus radius (5 μm) minus
bead radius. To run MC optimization, we used “Monte-
CarloWithLocalOptimization” with fie local steps and a
total of 500 iterations, which was sufficient to reach
convergence. Ten independent simulations were done
for comparison with Chrom3D structures.
To compare chromosome territories, we used the radius
of gyration, calculated as the root mean square distance of
the beads on each chromosome from their common cen-
ter of mass (using bead volume to represent the mass). To
estimate individual chromosome deviations from a spher-
ical shape, we used the asphericity measure based on the
eigenvalues of the gyration tensor [65].
Modeling of the α-globin gene locus
The ENm008 ENCODE region containing the α-globin
locus was modeled using Chrom3D based on published
5C chromosome conformation capture data [18]. For
each restriction fragment, we created beads (n = 70) of
diameter corresponding to the genomic length of the
fragment multiplied by 0.005 [18]. Preprocessing and
distance conversion rules for 5C data were as described
[18]. In contrast to the input file used for earlier 3D
reconstruction [18], we did not include distance con-
straints between neighboring beads since our modeling
framework represents each chromosome as a chain of
connected beads. Thus, distance constraints included
non-interaction constraints (two beads should not get
closer than a given distance) and interaction constraints
(two beads should not get further from each other than
a given distance). For all bead pairs with zero contacts
detected in the 5C contact matrix, we used non-
interaction constraints. Thresholds for non-interaction
and interaction distances were cell type-specific (K562
and GM12878 cells) [18]. We ran 1000 simulations for
each cell line using 40,000 iterations and a cooling rate
of 0.000125, excluding whole chromosome “Translation”
and “Rotation” moves. Final structures were aligned
using Procrustes analysis (procrustes method in the
vegan R package; default parameters with no scaling)
and clustered using agglomerative hierarchical clustering
(agnes method in the cluster R package; metric = “man-
hattan”). We extracted the cluster containing highest
proportion of simulated structures for each dataset and
plotted these on top of each other with high transpar-
ency so that the most common positions for each bead
are the most visible in the plot. Coloring scheme was ap-
proximated to the scheme used in Table 1 in [18]. Bead
sizes (in base-pairs) were: min 2; median 5151; mean
7043; max 29,050; bead radii in nm: min 0.01, median
25.76, mean, 35.21, and max 145.20. For distance calcu-
lations for comparison with FISH probes, we used beads
14 and 58 to calculate their distances across all struc-
tures for each cell line.
FISH probe design
The model nucleus was divided into two compartments
at rhalf_v = 3.97 μm distance from nuclear center (consid-
ering a 5 μm radius), each compartment being of equal
volume. This provided two regions for bead placement:
beads with centers located < rhalf_v from the nucleus cen-
ter were classified as central, and peripheral otherwise.
Proportions of each bead placed in peripheral or central
region across 400 structures were used to identify the
most stable beads in the periphery or center. Beads were
further filtered to select beads associated with LMNA
[7] (GEO GSE57149; track GSM1376181). We also de-
signed probes to beads that were neither stable in the
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periphery nor center (“intermediate” area). Additionally,
due to the variable copy number of genomic segments
in HeLa cells, probes were designed to avoid areas with
high copy number variations. Positions of FISH probes are
shown in Additional file 1: Figure S4a and FISH probe in-
formation is shown in Additional file 1: Table S1.
FISH procedure and signal detection
Cells were incubated in hypotonic buffer (0.25% KCl,
0.5% tri-sodium citrate) for 10 min and fixed in ice-
cold methanol:acetic acid (3:1). Cells were dropped on
slides. BAC FISH probes (BacPac Resource Center)
(Additional file 1: Table S1) were labeled using a Nick
Translation Kit and Biotin-16-dUTP (Roche). Per slide,
a 200–300 ng labeled probe was mixed with 8 μg
human Cot-1 DNA and 30 μg salmon sperm DNA
(Invitrogen) and precipitated. A DNA pellet was dis-
solved in 11 μL hybridization mix (50% deionized form-
amide (Ambion), 2× SSC, 1% Tween 20, 10% dextran
sulphate) at 42 °C for 20 min and pre-annealed for 1 h
at 37 °C. Slides were RNase-treated and washed twice
in 2× SSC, dehydrated in 70%, 90%, and 100% ethanol,
and air-dried. Slides were denatured for 1 min 20 s in
70 °C 70% deionized formamide/2× SSC, pH 7.5, dehy-
drated in ice-cold 70%, 90%, and 100% ethanol, and air-
dried. Probes were denatured for 5 min at 70 °C and
pre-annealed for 15 min at 37 °C. Ten microliters of
probe were applied onto coverslips (22 × 22 mm) which
were then mounted on a slide. Slides were hybridized
overnight at 37 °C. Slides were washed in 2× SSC (45 °C
2 min then 3× 5 min) and in 0.1× SSC (60 °C for 4×
4 min). Slides were blocked in 5% skim milk in 4×
SSC for 15 min at 37 °C and incubated at 37 °C for
30–60 min with Avidin Alexa Fluor 488 conjugate
(Invitrogen) (1.7 μg/mL in blocking buffer). Slides
were washed in 4× SSC/0.1% Tween 20 for 3× 5 min
and incubated with Biotinylated Anti-Avidin D conju-
gate (goat; 1.0 μg/mL in blocking buffer) (Vector) for
30 min at 37 °C. Slides were washed and incubated
with Avidin Alexa Fluor 488 conjugate as above.
Slides were mounted with 0.2 μg/mL DAPI in Dako
Fluorescent Mounting Medium.
A total of 484 FISH images were analyzed using FISH-
finder [66] to detect probes and calculate their position
relative to the nucleus edge (n = 1105 FISH signals). Im-
ages were taken in DeltaVision image stack format (.dv).
Significance of FISH signal localization in central, inter-
mediate, and peripheral regions was tested by Mann–
Whitney–Wilcoxon tests.
Data viewing
Browser views of ChIP-seq data are shown using Inte-
grated Genomics Viewer [67]. Genes are from Illumina
iGenomes gene annotation with UCSC source for hg19.
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